侨雄国际(00381.HK)附属以发行可转债方式收购湖北金草堂药业51%股权 作价1.7亿港元
格隆汇9月12日丨侨雄国际(00381.HK)公布,于9月11日,买方福建绿森农业科技有限公司(公司全资附属公司)与卖方Sheen World International Holdings Limited订立买卖协议,据此,公司收购而卖方出售销售权益(相当于目标公司湖北金草堂药业有限公司股权总额51%),代价为1.7亿港元,将由公司于完成后向卖方发行可换股债券支付。
公告显示,可换股债券每股兑换股份0.1港元,较收市价每股股份0.024港元溢价约316.67%。将基于兑换价0.1港元发行最多17亿股兑换股份,相当于公布日期公司现有已发行股本约17.19 %及公司经扩大后股本约14.67%。
据悉,目标公司的生产基地乃位于湖北十堰市竹山县,拥有的林地总面积为8,757亩,在林地附近建有生产厂房及设备。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.